To the Editor: In their review article on cytokine storm, Fajgenbaum and June (Dec. 3 issue)
1 include a discussion of signaling by mitogenactivated protein kinase (MAPK), nuclear …

While COVID-19, the disease driven by SARS-CoV-2 has ignited interest in the host immune
response to this infection, it has also highlighted the lack of treatment options for the …

After online publication of the article, 1 the editor noticed that Figs. 1 and 4 were produced
with the assistance of Servier Medical Art (https://smart. servier. com) without citation. The …

Abstract Although 15-20% of COVID-19 patients experience hyper-inflammation induced by
massive cytokine production, cellular triggers of this process and strategies to target them …

After its emergence in Wuhan, China, the rapid transmission of a novel betacoronavirus,
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to a worldwide …

Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
caused the greatest pandemic of our century. Many of the deaths related to it are due to a …

In spite of advances in vaccination, control of the COVID-19 pandemic will require the use of
pharmacological treatments against SARS-CoV2. Their development needs to consider the …

The world is facing a pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) for which no proven specific therapies are available other than supportive ones …

Janus kinase (JAK) inhibitors for the treatment of hospitalised patients with COVID-19 have
been extensively studied. Initially, at the start of the pandemic outside of China, baricitinib …

The cause of the COVID-19 pandemic can be attributed to the Acute Respiratory Syndrome
Virus-2 (SARS-CoV-2). COVID-19 manifests with severe symptoms in the upper respiratory …